Trade Names: | |
Synonyms: | |
Status: | Approved (1973) Withdrawn (1980) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N05CA01 |
UNII: | I4744080IR |
InChI Key | WEXRUCMBJFQVBZ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H18N2O3 |
Molecular Weight | 226.28 |
AlogP | 1.18 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 75.27 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 16.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
GABA-A receptor
|
50000 | 1700-40000 | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Two-pore domain potassium channel
|
- | - | - | - | 4 | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | - | - | - | 1-8 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 94 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Status Epilepticus | 3 | D013226 | ClinicalTrials |
Brain Injuries | 3 | D001930 | ClinicalTrials |
Heart Diseases | 1 | D006331 | ClinicalTrials |
Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 76-74-4 |
ChEBI | 7983 |
ChEMBL | CHEMBL448 |
DrugBank | DB00312 |
DrugCentral | 2095 |
EPA CompTox | DTXSID7023435 |
FDA SRS | I4744080IR |
Human Metabolome Database | HMDB0014457 |
Guide to Pharmacology | 5480 |
KEGG | C07422 |
PharmGKB | PA450859 |
PubChem | 4737 |
SureChEMBL | SCHEMBL24966 |
ZINC | ZINC00004840 |